Uncertainty in the diagnosis of cystic fibrosis: Possible role of in vivo nasal potential difference measurements

被引:45
作者
Wilson, DC
Ellis, L
Zielenski, J
Corey, M
Ip, WF
Tsui, LC
Tullis, E
Knowles, MR
Durie, PR
机构
[1] Hosp Sick Children, Res Inst, Div Gastroenterol & Nutr, Toronto, ON M5G 1X8, Canada
[2] Hosp Sick Children, Res Inst, Div Chest Med, Toronto, ON M5G 1X8, Canada
[3] Hosp Sick Children, Res Inst, Div Cyst Fibrosis Res, Toronto, ON M5G 1X8, Canada
[4] Univ Toronto, Wellesley Hosp, Adult Cyst Fibrosis Clin, Toronto, ON M4Y 1J3, Canada
[5] Univ N Carolina, Dept Med, Chapel Hill, NC USA
[6] Hosp Sick Children, Res Inst, Dept Genet, Toronto, ON M5G 1X8, Canada
[7] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada
[8] Univ Toronto, Dept Med & Mol Genet, Toronto, ON M5S 1A1, Canada
关键词
D O I
10.1016/S0022-3476(98)70345-2
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The diagnosis of cystic fibrosis (CF) is not always certain, despite extensive clinical evaluation, multiple sweat chloride tests, and genotype analysis. We hypothesized that nasal transepithelial potential difference measurements have a useful role in this situation. In 11 patients without an established diagnosis of CE results of simultaneous nasal potential difference (PD) and sweat chloride measurements were compared with those from control subjects, obligate CF heterozygotes, and patients with a confirmed diagnosis of CF. Two patients conformed to the PD profile for CF patients, whereas nine had values corresponding to those of the healthy control subjects. Subsequently the 5-thymidine (IVS8-5T) CF gene variant was identified in the two patients with abnormal PD measurements.
引用
收藏
页码:596 / 599
页数:4
相关论文
共 16 条
[1]   MUTATIONS IN THE CYSTIC-FIBROSIS GENE IN PATIENTS WITH CONGENITAL ABSENCE OF THE VAS-DEFERENS [J].
CHILLON, M ;
CASALS, T ;
MERCIER, B ;
BASSAS, L ;
LISSENS, W ;
SILBER, S ;
ROMEY, MC ;
RUIZROMERO, J ;
VERLINGUE, C ;
CLAUSTRES, M ;
NUNES, V ;
FEREC, C ;
ESTIVILL, X .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (22) :1475-1480
[2]   GENETIC-BASIS OF VARIABLE EXON-9 SKIPPING IN CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MESSENGER-RNA [J].
CHU, CS ;
TRAPNELL, BC ;
CURRISTIN, S ;
CUTTING, GR ;
CRYSTAL, RG .
NATURE GENETICS, 1993, 3 (02) :151-156
[3]  
Farrell PM, 1996, PEDIATRICS, V97, P524
[4]  
GIBSON LE, 1959, PEDIATRICS, V23, P545
[5]   THE RELATION BETWEEN GENOTYPE AND PHENOTYPE IN CYSTIC-FIBROSIS - ANALYSIS OF THE MOST COMMON MUTATION (DELTA-F508) [J].
KEREM, E ;
COREY, M ;
KEREM, BS ;
ROMMENS, J ;
MARKIEWICZ, D ;
LEVISON, H ;
TSUI, LC ;
DURIE, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (22) :1517-1522
[6]   IN-VIVO NASAL POTENTIAL DIFFERENCE - TECHNIQUES AND PROTOCOLS FOR ASSESSING EFFICACY OF GENE-TRANSFER IN CYSTIC-FIBROSIS [J].
KNOWLES, MR ;
PARADISO, AM ;
BOUCHER, RC .
HUMAN GENE THERAPY, 1995, 6 (04) :445-455
[7]   IMPAIRED CHLORIDE SECRETION, AS WELL AS BICARBONATE SECRETION, UNDERLIES THE FLUID SECRETORY DEFECT IN THE CYSTIC-FIBROSIS PANCREAS [J].
KOPELMAN, H ;
COREY, M ;
GASKIN, K ;
DURIE, P ;
WEIZMAN, Z ;
FORSTNER, G .
GASTROENTEROLOGY, 1988, 95 (02) :349-355
[8]  
KRISTIDIS P, 1992, AM J HUM GENET, V50, P1178
[9]   THE BENTIROMIDE TEST USING PLASMA PARA-AMINOBENZOIC ACID FOR DIAGNOSING PANCREATIC INSUFFICIENCY IN YOUNG-CHILDREN - THE EFFECT OF 2 DIFFERENT DOSES AND A LIQUID MEAL [J].
LAUFER, D ;
CLEGHORN, G ;
FORSTNER, G ;
ELLIS, L ;
KOREN, G ;
DURIE, P .
GASTROENTEROLOGY, 1991, 101 (01) :207-213
[10]   NASAL EPITHELIAL ION-TRANSPORT AND GENETIC-ANALYSIS OF INFERTILE MEN WITH CONGENITAL BILATERAL ABSENCE OF THE VAS-DEFERENS [J].
OSBORNE, LR ;
LYNCH, M ;
MIDDLETON, PG ;
ALTON, EWFW ;
GEDDES, DM ;
PRYOR, JP ;
HODSON, ME ;
SANTIS, GK .
HUMAN MOLECULAR GENETICS, 1993, 2 (10) :1605-1609